These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9710248)

  • 1. A dimeric bispecific miniantibody combines two specificities with avidity.
    Müller KM; Arndt KM; Plückthun A
    FEBS Lett; 1998 Jul; 432(1-2):45-9. PubMed ID: 9710248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first constant domain (C(H)1 and C(L)) of an antibody used as heterodimerization domain for bispecific miniantibodies.
    Müller KM; Arndt KM; Strittmatter W; Plückthun A
    FEBS Lett; 1998 Jan; 422(2):259-64. PubMed ID: 9490020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes.
    Connelly RJ; Hayden MS; Scholler JK; Tsu TT; Dupont B; Ledbetter JA; Kanner SB
    Int Immunol; 1998 Dec; 10(12):1863-72. PubMed ID: 9885907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimerisation strategies for shark IgNAR single domain antibody fragments.
    Simmons DP; Abregu FA; Krishnan UV; Proll DF; Streltsov VA; Doughty L; Hattarki MK; Nuttall SD
    J Immunol Methods; 2006 Aug; 315(1-2):171-84. PubMed ID: 16962608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of bispecific single chain antibodies expressed in Escherichia coli.
    Kranz DM; Gruber M; Wilson ER
    J Hematother; 1995 Oct; 4(5):403-8. PubMed ID: 8581376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Diabodies": small bivalent and bispecific antibody fragments.
    Holliger P; Prospero T; Winter G
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: multimerization effect on cell agglutination and application to blood typing.
    Furuta M; Uchikawa M; Ueda Y; Yabe T; Taima T; Tsumoto K; Kojima S; Juji T; Kumagai I
    Protein Eng; 1998 Mar; 11(3):233-41. PubMed ID: 9613848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
    Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
    J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody.
    Lu D; Jimenez X; Witte L; Zhu Z
    Biochem Biophys Res Commun; 2004 May; 318(2):507-13. PubMed ID: 15120630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM secretory tailpiece drives multimerisation of bivalent scFv fragments in eukaryotic cells.
    Olafsen T; Rasmussen IB; Norderhaug L; Bruland OS; Sandlie I
    Immunotechnology; 1998 Oct; 4(2):141-53. PubMed ID: 9853955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and characterisation of recombinant single-chain antibodies to the hapten Aflatoxin-B1 from naive recombinant antibody libraries.
    Moghaddam A; Løbersli I; Gebhardt K; Braunagel M; Marvik OJ
    J Immunol Methods; 2001 Aug; 254(1-2):169-81. PubMed ID: 11406162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of a novel tetravalent bispecific antibody that binds to hepatitis B virus surface antigens.
    Park SS; Ryu CJ; Kang YJ; Kashmiri SV; Hong HJ
    Mol Immunol; 2000 Dec; 37(18):1123-30. PubMed ID: 11451417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments.
    Lu D; Jimenez X; Zhang H; Bohlen P; Witte L; Zhu Z
    J Immunol Methods; 2002 Sep; 267(2):213-26. PubMed ID: 12165442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.
    Weber-Bornhauser S; Eggenberger J; Jelesarov I; Bernard A; Berger C; Bosshard HR
    Biochemistry; 1998 Sep; 37(37):13011-20. PubMed ID: 9737882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites.
    Yoshida S; Kobayashi T; Matsuoka H; Seki C; Gosnell WL; Chang SP; Ishii A
    Blood; 2003 Mar; 101(6):2300-6. PubMed ID: 12411309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear gene fusions of antibody fragments with streptavidin can be linked to biotin labelled secondary molecules to form bispecific reagents.
    Pearce LA; Oddie GW; Coia G; Kortt AA; Hudson PJ; Lilley GG
    Biochem Mol Biol Int; 1997 Sep; 42(6):1179-88. PubMed ID: 9305536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion.
    Kipriyanov SM; Little M; Kropshofer H; Breitling F; Gotter S; Dübel S
    Protein Eng; 1996 Feb; 9(2):203-11. PubMed ID: 9005442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
    Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
    Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.